Basilea Pharmaceutica AG

Other News To Note.
BIOWORLD Today; 11/3/2009; 2901 words; ...17 to treat gastrointestinal cancers, including pancreatic, gastric, esophageal and colorectal cancer. o Basilea Pharmaceutica AG, of Basel, Switzerland, received a second fast-track designation from the FDA for its broad-spectrum...

Clinic Roundup.
BIOWORLD Today; 11/3/2009; 943 words; o Basilea Pharmaceutica Ltd., of Basel, Switzerland, reported Phase III results showing that...Results were published in the Journal of Clinical Oncology. o MediGene AG, of Munich, Germany, completed patient recruitment for the Phase II...

Peninsula Acquired For $245M; PPI-0903 Destined For Spinout.
BIOWORLD Today; 11/3/2009; 1218 words; ...resistant Staphylococcus aureus antibiotic ceftobiprole from Basilea Pharmaceutica AG, of Basel, Switzerland, for clinical development...president of a North American business unit of Novartis AG, of Basel, Switzerland. The company was founded in...

Basilea Becomes Sole Owner Of BAL5788; Roche Opts Out.
BIOWORLD Today; 11/3/2009; 857 words; ...BioWorld International Correspondent Basilea Pharmaceutica AG gained outright ownership of its...dropped Basel, Switzerland-based Basilea's shares, which trade on the...the company CHF205.8 million. Basilea, which was formed in 2000 as...

Publication No. WO/2009/127623 Published on Oct. 22, Assigned to Basilea Pharmaceutica for Crystalline (Italian, German Inventors)
US Fed News Service, Including US State News; 10/29/2009; 360 words; ...Heubes and Michael Schleimer, both of Germany, have developed a Crystalline. The patent has been assigned to Basilea Pharmaceutica AG, Basel, Switzerland. According to an abstract posted by the World Intellectual Property Organization: "A...